Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. META
3. CCHGY
4. PRY:IM
5. PRYMY
6. SPY
7. SKA-B
8. PBA
9. ALAR
10. CCH:LN

Go back to Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)

Leerink Partners Reiterates Outperform Rating on Repligen (RGEN)

March 4, 2025 9:50 AM EST

Leerink Partners analyst Puneet Souda reiterated an Outperform rating and $200.00 price target on Repligen (NASDAQ: RGEN)

The analyst comments "Bottom Line: This morning, RGEN (OP) announced the acquisition of MASS's (MP) bioprocessing desktop portfolio including REBEL, MAVERICK/MAVEN, and ZipChip (overall ~450 total... More